Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-31, Stock:LLY, The news for the past five days is as follows:
2018-07-24: NEWS1: Asian Markets Exhibit Mixed Trend.NEWS2: Asian Markets Exhibit Mixed Trend.NEWS3: Renewed Support Predicted For Thai Stock Market.NEWS4: Renewed Support Predicted For Thai Stock Market.NEWS5: Japanese Market Rises.NEWS6: Japanese Market Rises.NEWS7: Indonesia Bourse May Add To Its Winnings.NEWS8: Indonesia Bourse May Add To Its Winnings.NEWS9: Australian Market Drifts Lower.NEWS10: Australian Market Drifts Lower.NEWS11: Win Streak May Continue For Hong Kong Shares.NEWS12: Win Streak May Continue For Hong Kong Shares.NEWS13: Edited Transcript of LLY earnings conference call or presentation 24-Jul-18 1:00pm GMT.NEWS14: China Stocks Draw Positive Lead For Wednesday.NEWS15: China Stocks Draw Positive Lead For Wednesday.NEWS16: S&P reaches highest level since February as Alphabet shares soar.NEWS17: Taiwan Bourse May Crack Resistance At 11,000 Points.NEWS18: Taiwan Bourse May Crack Resistance At 11,000 Points.NEWS19: Health Care Sector Update for 07/24/2018: BMY,BIIB,IMRN,LLY.NEWS20: Health Care Sector Update for 07/24/2018: BMY,BIIB,IMRN,LLY.NEWS21: Singapore Bourse May Find Traction On Wednesday.NEWS22: Singapore Bourse May Find Traction On Wednesday.NEWS23: Malaysia Shares May See Continued Support.NEWS24: Malaysia Shares May See Continued Support.NEWS25: Mild Upside Seen For South Korea Stock Market.NEWS26: Mild Upside Seen For South Korea Stock Market.NEWS27: Health Care Sector Update for 07/24/2018: BIIB,IMRN,LLY.NEWS28: Health Care Sector Update for 07/24/2018: BIIB,IMRN,LLY.NEWS29: AstraZeneca Sells Atacand's European Rights to Cheplapharm.NEWS30: AstraZeneca Sells Atacand's European Rights to Cheplapharm.NEWS31: Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco.NEWS32: Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco.NEWS33: Lilly plans Elanco IPO, posts quarterly profit above estimates.NEWS34: Eli Lilly's Good Quarter Masks Deeper Risks.NEWS35: Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates.NEWS36: Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates.NEWS37: AstraZeneca Sells Atacand&apos;s European Rights to Cheplapharm.NEWS38: Biogen, Eli Lilly earnings beats push industry stocks up.NEWS39: Stocks - Alphabet, Harley-Davidson, Verizon Gain in Pre-market; Whirlpool Tanks.NEWS40: Eli Lilly and Company -- Moody's: Lilly's planned separation of Elanco is credit negative.NEWS41: Lilly (LLY) Tops Q2 Earnings, Chooses IPO Path for Elanco.NEWS42: Johnson & Johnson Updated Fiscal 2018 Guidance.NEWS43: How Eli Lilly’s Segments Performed in Q2 2018.NEWS44: Biotech ETFs surge, supported by strong results from Biogen and Eli Lilly.NEWS45: Eli Lilly (LLY) Tops Q2 Earnings and Revenue Estimates.NEWS46: Alphabet Isn't the Only Company With an Earnings Blowout - Here's the Rundown.NEWS47: Drugmaker Lilly plans IPO for part of animal health business.NEWS48: Corrected: Eli Lilly to take animal health unit public, profit beats estimates.NEWS49: Stocks to Watch: Alphabet, Verizon, Whirlpool, Harley-Davidson, 3M, Lockheed Martin, Eli Lilly.NEWS50: Benzinga Pro's 5 Stocks To Watch Today.NEWS51: Eli Lilly (LLY) Tops Q2 Earnings & Sales, Ups 2018 View.NEWS52: Eli Lilly (LLY) Tops Q2 Earnings & Sales, Ups 2018 View.NEWS53: Eli Lilly Shares Climb on Earnings Beat.NEWS54: Eli Lilly Surpasses Estimates, Reports Growth in Q2 2018.NEWS55: Eli Lilly Plans to Separate Elanco through Potential IPO.NEWS56: Eli Lilly to take animal health unit public.NEWS57: Eli Lilly Won't Raise Drug Prices This Year, CEO Says.NEWS58: Eli Lilly Won't Raise Drug Prices This Year, CEO Says.NEWS59: Stocks Remain Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS60: Stocks Remain Mostly Positive In Mid-Day Trading - U.S. Commentary.NEWS61: Eli Lilly (LLY) Tops Q2 Earnings & Sales, Ups 2018 View.NEWS62: Stocks making the biggest moves premarket: MMM, UTX, VZ, LLY & more.NEWS63: Analysts’ Targets and Recommendations for Amgen Stock.NEWS64: Eli Lilly tops 2Q earnings, guidance expectations.NEWS65: [$$] Eli Lilly plans listing of animal health unit.NEWS66: Eli Lilly CEO: We're growing based on the back of our new....NEWS67: Eli Lilly spins off animal health unit, second quarter beats.NEWS68: Eli Lilly shares rise after animal health IPO, earnings beat.NEWS69: Eli Lilly shares surge after animal health IPO, earnings beat.NEWS70: Eli Lilly&apos;s stock jumps after earnings beat, potential IPO of Elanco Animal Health.NEWS71: Earnings Reaction History: Eli Lilly & Co., 36.4% Follow-Through Indicator, 2.2% Sensitive.NEWS72: Earnings Reaction History: Eli Lilly & Co., 36.4% Follow-Through Indicator, 2.2% Sensitive.NEWS73: Stocks Move Notably Higher On Upbeat Earnings News - U.S. Commentary.NEWS74: Stocks Move Notably Higher On Upbeat Earnings News - U.S. Commentary.NEWS75: Eli Lilly to take animal health unit public.NEWS76: Lilly Opts for Animal-Drugs Spinoff Instead of Selling Unit.NEWS77: Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance.NEWS78: Eli Lilly plans initial public offering of its Elanco animal health unit.NEWS79: Lilly to Separate Elanco Animal Health with Initial Public Offering.NEWS80: Dow is set to rise nearly 150 points following strong earnings from Google parent Alphabet.NEWS81: Dow futures are set to rise following strong earnings from Google parent Alphabet.NEWS82: US futures tick higher as earnings season picks up.NEWS83: Stocks May Move To The Upside In Early Trading - U.S. Commentary.NEWS84: Stocks May Move To The Upside In Early Trading - U.S. Commentary.NEWS85: Eli Lilly Q2 18 Earnings Conference Call At 9:00 AM ET.NEWS86: Eli Lilly Q2 18 Earnings Conference Call At 9:00 AM ET.NEWS87: Eli Lilly Revises Guidance; To Pursue IPO Of Elanco - Quick Facts.NEWS88: Eli Lilly Revises Guidance; To Pursue IPO Of Elanco - Quick Facts.NEWS89: Eli Lilly And Co. Q2 18 Earnings Conference Call At 9:00 AM ET.NEWS90: Eli Lilly And Co. Q2 18 Earnings Conference Call At 9:00 AM ET.
2018-07-25: NEWS1: AbbVie Secures FDA Approval for Endometriosis Drug Elagolix.NEWS2: AbbVie Secures FDA Approval for Endometriosis Drug Elagolix.NEWS3: Company News For Jul 25, 2018.NEWS4: Company News For Jul 25, 2018.NEWS5: AbbVie Secures FDA Approval for Endometriosis Drug Elagolix.NEWS6: Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More.NEWS7: Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More.NEWS8: Noteworthy ETF Outflows: XLV, PFE, LLY, TMO.NEWS9: Noteworthy ETF Outflows: XLV, PFE, LLY, TMO.NEWS10: Company News For Jul 25, 2018.NEWS11: Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More.NEWS12: S&P 500’s Top Gainers: Avery Dennison and Harley-Davidson.NEWS13: Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Eli Lilly and Company.NEWS14: Earnings Boost U.S. Stocks.NEWS15: [$$] Eli Lilly to Offer Minority Stake in Animal-Health Business.
2018-07-26: NEWS1: Allergan Reports Strong Revenue Growth and Q2 2018 Earnings.NEWS2: Celgene Raises Revenue Guidance after Solid Growth in Q2 2018.NEWS3: Analysts’ Recommendations for Sanofi Stock before Q2 Results.NEWS4: AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up.NEWS5: AstraZeneca's (AZN) Q2 Earnings and Sales Beat, Stock Up.NEWS6: Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan.NEWS7: Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan.NEWS8: Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up.NEWS9: Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, '18 View Up.NEWS10: Allergan (AGN) Beats on Q2 Earnings, Unveils Buyback Plan.NEWS11: LLY Crosses Above Average Analyst Target.NEWS12: LLY Crosses Above Average Analyst Target.NEWS13: Glaxo (GSK) Q2 Earnings & Sales Beat Estimates, &apos;18 View Up.NEWS14: ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions.NEWS15: ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions.NEWS16: ABBV, MRK Q2 Earnings on Jul 27: Here are the Key Predictions.NEWS17: Initiating Free Research Reports on Pfizer and Three Other Drug Makers Equities.NEWS18: FOCUS-Amgen's new migraine drug hits insurance hurdles.NEWS19: FOCUS-Amgen's new migraine drug hits insurance hurdles.
2018-07-27: NEWS1: Merck (MRK) Q2 Earnings & Sales Top on Keytruda Strength.NEWS2: Merck (MRK) Q2 Earnings & Sales Top on Keytruda Strength.NEWS3: Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod.NEWS4: Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV's Elagolix Gets FDA Nod.NEWS5: Merck Witnessed 5% Growth in Q2 2018.NEWS6: Pharma Stock Roundup: LLY, AGN Post Solid Q2 Results, ABBV&apos;s Elagolix Gets FDA Nod.NEWS7: Pfizer’s Q2 2018 Earnings: Analysts’ Estimates.NEWS8: Merck (MRK) Q2 Earnings & Sales Top on Keytruda Strength.NEWS9: Incyte (INCY) to Report Q2 Earnings: What's in the Cards?.NEWS10: Incyte (INCY) to Report Q2 Earnings: What's in the Cards?.NEWS11: New Research: Key Drivers of Growth for ICU Medical, A. Schulman, Verso, Eli Lilly, Spectrum Pharmaceuticals, and Intuit — Factors of Influence, Major Initiatives and Sustained Production.
2018-07-30: NEWS1: What to Expect from Incyte’s Q2 2018 Earnings on July 31.NEWS2: How Celgene’s Otezla and Abraxane Did in Q2 2018.NEWS3: A Look at Celgene’s Financials in Q2 2018.NEWS4: WisdomTree U.S. Dividend ex-Financials Fund -- Insider Buying Index Registering 10.2%.NEWS5: WisdomTree U.S. Dividend ex-Financials Fund -- Insider Buying Index Registering 10.2%.NEWS6: See what the IHS Markit Score report has to say about Eli Lilly And Co..NEWS7: Lilly Announces Extension of Cancer Research Collaboration with Dana-Farber Cancer Institute.

Answer: Rise